Rafferty Asset Management, LLC Repligen Corp Transaction History

Rafferty Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$73.84 - $93.08 $6 Million - $7.57 Million	-81,308 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $2.77 Million - $3.45 Million	36,167 Added 80.12%	81,308 $6.24 Million
Q2 2019 Aug 09, 2019	SELL	$54.2 - $85.95 $393,166 - $623,481	-7,254 Reduced 13.84%	45,141 $3.88 Million
Q1 2019 May 15, 2019	BUY	$49.45 - $62.8 $2.59 Million - $3.29 Million	52,395 New	52,395 $3.1 Million

486

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.87B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.